US WorldMeds
KY - LouisvillePharmaceutical
Focus: US WorldMeds is a specialty pharmaceutical company headquartered in Louisville, KY, focused on neurology and rare disease treatments. The company operates as a public-stage entity with a lean 8-role active job count.
Profile data last refreshed 8h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
9
Should You Work at US WorldMeds?
AI assessmentUS WorldMeds offers meaningful exposure to emerging cell therapy and specialty pharma development with recent regulatory wins, but small scale and data opacity present career continuity risk.
Why Work Here
- Early-stage pipeline with emerging FDA approvals: TECELRA® (afamitresgene autoleucel) received full FDA approval in June 2026 for solid tumors in pediatric patients, signaling commercial momentum.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Late-stage
5 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Non-conforming afamitresgene autoleucel
Synovial SarcomaClinical Trials (1)
NCT06617572Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel
N/AHelp build intelligence for US WorldMeds
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.